2.Oh DY, et al. Analysis of clinically actionable alterations in baseline tumor versus plasma samples in participants of the TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. 2025...
1. Oh DY, et al. Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in advanced biliary tract cancer (aBTC)2024 ESMO ASIA 135P. 2. Oh DY, He AR, Bouattour M, et al. Durvalumab or plac...
1. J.W. Valle, et al. 68O - Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+GC) in advanced biliary tract cance...
4. Takuji Okusaka, et al. 93P - Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study. ESMO Asia Congress 2022. Annals of Oncology (2022) 33 (suppl_9): S1454-S1484. 10.1...
1. Toyoda H, et al. Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in Japan. Aliment Pharmacol Ther. 2022; 56: 694– 701. ...
2. Do-Youn Oh, et al. 78P - Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC). ESMO Asia Congress 2022. Annals of Oncology (2022) 33...
Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer.21531 Background: At the primary analysis of TOPAZ-1 (NCT03875235; data cut-off [DCO] Aug 11, 2021), durvalumab (D) + gemcitabine and ...
How do design decisions impact the quality of the resulting software? In an empirical study of 52 ECLIPSE plug-ins, we found that the software design as well as past failure history, can be used to build models which accurately predict f... ...
Key Topics in this News Article: News Snapshot: The latest EMT Conduit Fittings market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading fa...
In the constant race for more megapixels, ON1 Resize AI offers a pause. Instead of upgrading to the latest and greatest sensor, it lets you recover details you thought were lost.